Janus Henderson Group PLC Bicycle Therapeutics PLC Transaction History

Janus Henderson Group PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$19.9 - $26.25 $7.37 Million - $9.72 Million	-370,394 Reduced 28.91%	910,930 $18.3 Million
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $3.66 Million - $5.53 Million	-193,054 Reduced 13.09%	1,281,324 $32.7 Million
Q1 2023 May 15, 2023	SELL	$20.02 - $31.37 $581,961 - $911,894	-29,069 Reduced 1.93%	1,474,378 $31.4 Million
Q4 2022 Feb 14, 2023	SELL	$20.37 - $32.9 $3.61 Million - $5.84 Million	-177,402 Reduced 10.55%	1,503,447 $44.5 Million
Q3 2022 Nov 14, 2022	BUY	$17.49 - $28.44 $5.36 Million - $8.71 Million	306,360 Added 22.29%	1,680,849 $39.1 Million

Q2 2022 Aug 15, 2022	SELL	$12.95 - $46.99 $4.12 Million - $15 Million	-318,285 Reduced 18.8%	1,374,489 $23.1 Million
Q1 2022 May 16, 2022	SELL	$40.12 - $59.5 $105,716 - $156,782	-2,635 Reduced 0.16%	1,692,774 $74.3 Million
Q4 2021 Feb 14, 2022	SELL	$41.7 - $61.14 $1.98 Million - $2.91 Million	-47,596 Reduced 2.73%	1,695,409 $103 Million
Q3 2021 Nov 16, 2021	SELL	$27.95 - $44.24 $2.98 Million - $4.72 Million	-106,715 Reduced 5.77%	1,743,005 $72.6 Million
Q2 2021 Aug 16, 2021	BUY	$27.0 - $32.28 $4.21 Million - $5.04 Million	156,062 Added 9.21%	1,849,720 $56.2 Million
Q1 2021 May 17, 2021	BUY	$19.12 - $30.25 $32.4 Million - $51.2 Million	1,693,658 New	1,693,658 $50.7 Million

30.6M

85.5K

11.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $600M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.